CUSIP 81728A108COMSNSEQ1 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ1 2025
19 funds hold this security · Q1 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 585.6K | $230.7K | +585.6K | New Position |
| 2 | Ikarian Capital, LLC | 450.0K | $177.3K | +450.0K | New Position |
| 3 | Catalio Capital Management, LP | 294.4K | $116.0K | +294.4K | New Position |
| 4 | Renaissance Technologies LLC | 177.3K |
| $69.9K |
| +177.3K |
| New Position |
| 5 | Geode Capital Management, LLC | 150.7K | $59.4K | +150.7K | New Position |
| 6 | Boothbay Fund Management, LLC | 108.7K | $42.8K | +108.7K | New Position |
| 7 | Ubs Group AG | 42.5K | $16.8K | +42.5K | New Position |
| 8 | Northern Trust Corp | 26.0K | $10.2K | +26.0K | New Position |
| 9 | State Street Corp | 25.8K | $10.2K | +25.8K | New Position |
| 10 | Cresset Asset Management, LLC | 19.7K | $7.8K | +19.7K | New Position |
See every fund holding Sensei Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders